|
|
||||||||
1 Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, Iowa 50010, USA
2 Department of Chemical Engineering, Iowa State University, Ames, Iowa 50010, USA
3 Program of Bioinformatics and Computational Biology, Iowa State University, Ames, Iowa 50010, USA
4 Department of Physiology, Cornell University Medical College, New York, New York 10021, USA
Reprint requests to: Dr. Amy H. Andreotti, Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50010; e-mail: amyand{at}iastate.edu; fax: (515) 294-0453.
(RECEIVED July 3, 2001; FINAL REVISION September 15, 2001; ACCEPTED October 4, 2001)
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1101/ps.26702.
| Abstract |
|---|
|
|
|---|
Keywords: Bruton's tyrosine kinase (Btk); SH3; NMR; asymmetric homodimer; intramolecular; self-association
| Introduction |
|---|
|
|
|---|
|
| Results |
|---|
|
|
|---|
To determine the precise role of the two proline sequences in mediating dimerization of PrPrSH3, we characterized two additional Btk `single' mutants, Pr*PrSH3 and PrPr*SH3 (see Fig. 1A
caption), by NMR spectroscopy. First, NMR line widths were analyzed at high (1.5 to 2.0 mM) and low (0.03 to 0.05 mM) concentrations to determine the predominant aggregation state of the single mutants. At high concentration, average NMR line widths ranged from 24 to 31 Hz for both single mutants and wild-type PrPrSH3, whereas they ranged from 15 to 19 Hz for all three proteins at low concentrations. Line widths for Pr*Pr*SH3 were constant between 0.4 and 3.5 mM and ranged from 15 to 19 Hz. Thus, Btk fragments that contain at least one intact proline motif dimerize in solution, whereas the double mutant does not. To ascertain whether dimerization of the single mutants occurs via interactions mediated by the SH3 binding pocket contacting the proline-rich ligand, the chemical shift differences between each of the single mutants and Pr*Pr*SH3 were analyzed. Significant chemical shift perturbations occur for the same residues as were identified for wild-type Btk PrPrSH3 when compared to double mutant and therefore map out the same well-defined binding pocket of the SH3 domain (Fig. 1C
). However, the magnitude of the chemical shift changes for the single mutants compared with Pr*Pr*SH3 appears to be less than that for wild-type protein (Fig. 1B
).
Progressive changes in the positions of 21 of 67 cross-peaks in the HSQC spectra of each of the proteinsPrPrSH3, Pr*PrSH3, and PrPr*SH3were observed as protein concentration was varied. Representative plots of the proton resonance frequency of W251(NH
) versus protein concentration are shown in Figure 2
for the two single mutants, wild-type Btk PrPrSH3, and the monomeric `double' mutant Pr*Pr*SH3. For a system in fast exchange, the observed chemical shift is the weighted average of the chemical shifts of reporters in the two exchanging species, as given by Equation 1
(Cheng and Shirts 1985):
![]() | ((1)) |
obs,
m, and
d are the observed, monomeric (at infinite dilution) and dimeric (at infinite concentration) chemical shifts, respectively. The mole fraction of dimer (fd) is calculated according to a monomer-dimer equilibrium model (Equation 2
![]() | ((2)) |
|
| ((3)) |
|
m, and
d values were determined by three parameter least-squares fitting of Equation 1
; shown in Fig. 2
Analysis of the extrapolated monomeric chemical shifts (
m)
The system is in fast exchange, relative to the NMR time scale, and so the magnitude of the chemical shift perturbations for residues in the SH3 binding pocket can be used as a measure of relative SH3 occupancy by a proline ligand. Interestingly, the asymptotic limits of the binding curves (and therefore SH3 occupancy in the monomeric and dimeric forms) for each of the related Btk fragments are different. As can be seen in Figure 2
, the monomeric chemical shifts (denoted
mintra) for PrPrSH3 and PrPr*SH3 are nearly equal. The corresponding values for the Pr*PrSH3 mutant and the double mutant (denoted
mPr*Pr*) are also nearly equal and are different from
mintra. This is the case for all SH3 residue frequencies that show significant concentration-dependent chemical shift changes.
To explain these results, we propose a structural model for Btk in which the amino-terminal proline sequence contacts the adjacent SH3 domain binding pocket in an intramolecular fashion in both wild-type PrPrSH3 and PrPr*SH3 (Fig. 3A
). The Btk intramolecular interaction competes directly with dimer formation because both binding events require occupancy of the same SH3 binding pocket. The value of
m for the Pr*PrSH3 mutant indicates that the carboxy-terminal proline stretch within Btk does not contact the SH3 pocket in an intramolecular fashion. The intramolecular association mode observed here for Btk is analogous to that observed previously for the homologous proline SH3-containing Itk fragment (Andreotti et al. 1997). However, the Itk fragment does not dimerize at higher concentrations.
|
d)
d) also reveal differences among the Btk constructs studied. The limits of the chemical shift at high concentration for both single mutants (denoted
dPr*Pr and
dPrPr* in Fig. 2
dPrPr in Fig. 2
We have established that both Btk single mutants (Pr*PrSH3 and PrPr*SH3) and wild-type PrPrSH3 dimerize and that the extent of SH3 occupancy in the single mutants and wild type is different. Furthermore, the molecular surface mapped by chemical shift perturbations is the same in all three cases and corresponds to the SH3 proline binding pocket. If only a single proline stretch were responsible for the intermolecular association in wild-type PrPrSH3, then either the Pr*PrSH3 or the PrPr*SH3 mutant would not dimerize, whereas the other single mutant would behave similarly to wild type. Thus, the most plausible structural model for Btk PrPrSH3 dimerization is an asymmetric homodimer in which one of the two SH3 binding pockets in the dimer contacts the amino-terminal proline sequence, whereas the other SH3 domain binds to the carboxy-terminal proline sequence (Fig. 3C
).
Mixture of complimentary mutants mimic wild-type Btk PrPrSH3
To ascertain whether the PrPrSH3 fragment forms the proposed asymmetric homodimer, we performed NMR titration experiments using mixtures of complimentary single mutants. As we have already shown, the single mutants alone form a homodimer in which one of the SH3 proline binding sites is unoccupied (Fig. 3B
). However, for a mixture of single mutants (Pr*PrSH3 and PrPr*SH3), formation of the asymmetric heterodimer in a manner that mimics the putative wild-type asymmetric homodimer (i.e., having two occupied proline binding sites) is possible (Fig. 3D
).
Addition of unlabeled single mutant (Pr*PrSH3) into a sample of the 15N-labeled complimentary mutant (PrPr*SH3) should shift the equilibrium toward occupied SH3 domain if asymmetric homodimerization occurs. Indeed, the position of the cross-peak corresponding to W251(NH
; Fig. 4A
) shifts significantly in the presence of 0.2 and then 0.4 equivalents of complimentary unlabeled Pr*PrSH3 mutant. Similar shifts are observed for all SH3 cross-peaks, corresponding to residues in the proline binding pocket. The direction of the observed chemical shift perturbation is toward that of occupied SH3 domain (i.e., that of 1 mM wild-type PrPrSH3). The only proline motif that can cause the observed shift is the carboxy-terminal stretch of the unlabeled mutant (Pr*PrSH3), which binds to the SH3 pocket of 15N-labeled PrPr*SH3 in an intermolecular fashion. In the reverse titration (addition of unlabeled PrPr*SH3 into a sample of 15N-labeled Pr*PrSH3), similar chemical shift perturbations are observed (Fig. 4B
). In this case, the amino-terminal proline stretch must be responsible for the observed shifts in the labeled SH3 domain. Combined, these data show that asymmetric dimer formation is possible.
|
Quantitative analysis of the competing equilibria
The predicted concentration dependence of the resonance frequencies for each cross-peak and the observed experimental values are plotted in Figure 4C
. The equilibrium model used to predict the concentration dependence of the chemical shifts for the mixture of single mutants was developed by first determining K`a, the intramolecular association constant of either PrPr*SH3 or PrPrSH3. Because both SH3 pockets are occupied in wild-type PrPrSH3 dimer,
dPrPr (see Fig. 2
) is the chemical shift of a species with fully occupied SH3 pockets, whereas
Pr*Pr*m represents the chemical shift of the unoccupied species. We can therefore calculate K`a as the ratio of occupied to unoccupied SH3 pockets in the monomer, as defined in Equation 4
,
|
| ((4)) |
Pr*Pr*m is the chemical shift of Pr*Pr*SH3, and
PrPrd is the extrapolated chemical shift of dimeric PrPrSH3.
intram is the extrapolated chemical shift corresponding to either monomeric wild-type PrPrSH3 or monomeric PrPr*SH3. The determined values of K`a are 0.28±0.05 and 0.29±0.06 for Btk PrPrSH3 and PrPr*SH3, respectively.
We assume that the system is at equilibrium and that six species are present: PrPr*SH3 monomer intramolecularly bound, PrPr*SH3 monomer not intramolecularly bound, Pr*PrSH3 monomer, PrPr*SH3 homodimer, Pr*PrSH3 homodimer, and Pr*PrSH3 plus PrPr*SH3 heterodimer. These are denoted A`, A, B, A2, B2, and AB, respectively. Four equations govern the system (Equations 58![]()
![]()
![]()
):
![]() | ((5)) |
![]() | ((6)) |
![]() | ((7)) |
![]() | ((8)) |
Secondly, the SH3 occupancy of the dimeric forms of both single mutants is taken to be half that of wild-type PrPrSH3.
The four association constants defined in Equations 5 through 8![]()
![]()
![]()
are determined through analysis of the distinct association mechanisms of mutant and wild-type fragments. The only association mechanism for Pr*PrSH3 (denoted B) is dimerization without competition from intramolecular self-association, and so the observed association constant for this protein can be used as the value for Kb in Equation 7
. The K`a value determined using Equation 4
is used for K`a in Equation 5
.
We have already determined KMDa for PrPr*SH3 and PrPrSH3 using a simple monomer-dimer equilibrium model (Equation 2
). However, the conformational ensemble of these proteins includes the intramolecular complex in addition to dimer. Therefore, three species are presentintramolecularly bound monomer (A`), free monomer (A), and dimer (A2)and two equations govern the system (i.e., Equations 5, 6![]()
). It can be shown (see Supplementary Material) that the observed association constant (KMDa) obtained when fitting a simple monomer-dimer equilibrium model to a system governed by Equations 5 and 6![]()
is related to K`a and Ka by Equation 9
.
|
| ((9)) |
Including the mass balance for species A and B, we have a set of six equations with six unknowns that can be solved numerically. The equilibrium concentration of all species present can thus be calculated as a function of the total amount of each complimentary mutant in solution. The observed chemical shift for each species can then be computed by using Equation 1
, with
Pr*Pr*m and
PrPrd substituted for
m and
d, respectively. The fd parameter in Equation 1
thus becomes the mole fraction of occupied to total SH3 pockets giving rise to the NMR signal. For the cross-peak corresponding to Pr*PrSH3, the value of fPr*PrSH3 is calculated using Equation 10
:
|
| ((10)) |
Similarly, for the cross-peak resulting from the PrPr*SH3 species, fPrPr*SH3 is defined in Equation 11
:
|
| ((11)) |
We predicted the concentration-dependent behavior of both cross-peaks in Figure 4C
based only on the results of our initial experiments without adjusting any parameters. The agreement between the predicted and experimental concentration behavior supports the assumptions made in our model. Importantly, the assumption that the free energy of heterodimer formation (Pr*PrSH3 plus PrPr*SH3) is equal to that of wild-type PrPrSH3 homodimer formation is borne out by the accurate prediction of experimental observations.
A priori, it is not evident that the free energy of formation of the heterodimer should equal that of the homodimer. From a statistical mechanical standpoint, we must consider the effect of the distinguishability of the two subunits on the free energy of formation of the heterodimer. Consider a symmetry operation that interconverts the two monomeric subunits of the putative PrPrSH3 dimer as shown in Figure 3E
. If we do not distinguish between the two monomeric subunits (i.e., the dimer is a homodimer), then the dimers in Figure 3E
are identical. Therefore, a homodimer has a symmetry number of two (Davidson 1962). If we now consider the monomeric subunit (SH3`) to be distinguishable from the other SH3 (e.g., a residue not involved in mediating dimerization is mutated in SH3`), then the two dimers in Figure 3E
are not identical. The symmetry number of the resulting heterodimer will be one, because no symmetry operation other than identity yields an identical dimer. A consequence of this difference in symmetry numbers is that the association constant of the heterodimer will be twice that of the homodimer (Davidson 1962; Ben-Naim 1992). One might therefore expect the association constant of the heterodimer formed by mixing Pr*PrSH3 and PrPr*SH3 to be twice that of the wild-type PrPrSH3 homodimer.
The heterodimer formed by mixing Pr*PrSH3 and PrPr*SH3 is different from the case described above in that the residues we mutate are involved in mediating dimerization. In the Btk heterodimer (Fig. 3D
), two of the four SH3 ligands (proline rich stretches) that mediate dimerization are mutated. As a result, we have eliminated half of the potential stable structures contributing to the association constant of the heterodimer. This cancels out the factor of two in the association constants that would arise because of the different symmetry numbers of the homo- and heterodimers. Thus, the association constants of the Btk hetero- and homodimer will be equal, resulting in equal free energies of formation as assumed in our prediction (Fig. 4C
).
The free energies of formation of the homo- and heterodimers may nonetheless differ because of changes in solvation energies or conformational differences that are the result of proline to alanine mutations. However, given the good agreement between predicted and observed experimental values, we believe these differences are negligible. Thus, the data support the wild-type asymmetric self-association model depicted in Figure 3C
.
| Discussion |
|---|
|
|
|---|
The association constants for each of the binding events involving the Btk PrPrSH3 fragment were measured by the combined application of mutagenesis and NMR spectroscopy. The concentration dependence of the mixture of complimentary mutants was accurately predicted by assuming a similar asymmetric association mode to that of wild-type Btk PrPrSH3. It appears that the lower occupancy association modes (Fig. 3B
) for the single mutants (PrPr*SH3 and Pr*PrSH3) are not significantly populated in the case of wild-type PrPrSH3. Rather, the Btk PrPrSH3 fragment favors formation of the asymmetric homodimer structure.
The measured association constants indicate that dimerization of Btk PrPrSH3 is a relatively weak interaction. The studies presented here were performed on a small fragment of Btk, and it is conceivable that full-length protein may dimerize via the interactions described here but with greater affinity. In fact, dimerization of full-length Btk has been observed in both gel-filtration assays and mammalian cell systems (X.-Y. Huang, unpubl.). Interestingly, fragments of Itk comprised of the SH3 and SH2 domains also form dimers in solution, albeit via molecular contacts that are distinct from the proline-SH3 interactions described here (Brazin et al. 2000). Together with X-ray crystallographic data that indicate that the PH domain of Btk has a propensity to dimerize (Hyvonen and Saraste 1997), it is becoming apparent that the regulatory domains of the Tec kinases are predisposed under some conditions to form specific dimers.
It is possible that self-association plays a role in regulating Tec family kinase activity. Biochemical investigations into the mechanism of Btk regulation have indicated that PH domainphosphatidylinositol recognition is responsible for translocating Btk to the plasma membrane where activation proceeds (Kawakami et al. 1994; Li et al. 1997; Bolland et al. 1998; Nisitani et al. 1999). Membrane association is likely accompanied by an increase in the local concentration of Btk that would shift the equilibrium toward dimer. Thus, the intra- and intermolecular species that we have described for the PrPrSH3 fragment of Btk may represent conformational states at distinct points along the activation pathway.
DNA mutations in both proline-rich regions and the SH3 domain of the Btk gene have been detected in XLA patients (Vihinen et al. 1999). Our results show that mutations in either the amino- or carboxy-terminal proline stretches have profoundly different effects on the dominating species in solution. Mutation of the amino-terminal proline sequence (Pr*PrSH3) eliminates the intramolecular interaction. Mutations in the SH3 pocket that reduce the affinity of the domain for proline-rich sequences would be expected to have the same effect as mutation of both proline stretches (Pr*Pr*SH3): elimination of both intra- and intermolecular association. Thus, the competing equilibria (intra- and intermolecular association) involving the PrPrSH3 fragment present a novel system for control of the monomer-dimer equilibrium that could be significantly altered by genetic mutation.
Any exogenous molecule with affinity for either proline sequence or the SH3 domain of Btk (Cheng et al. 1994; Yang et al. 1995) also has the potential to significantly alter the equilibrium species composition of wild-type PrPrSH3. In fact, direct interactions between a heterotrimeric guanine nucleotide-binding protein and the region of Btk that contains the PrPrSH3 sequence studied here result in stimulation of Btk kinase activity (Bence et al. 1997; Ma and Huang 1998). It is also possible that the mechanism of G protein activation is linked to changes in the Btk monomer-dimer equilibrium. As the precise signaling events that control Btk kinase activation are elucidated, it will be important to consider how the intra- and intermolecular modes of self-association presented here contribute to substrate binding and control of catalytic activity.
| Materials and methods |
|---|
|
|
|---|
| Electronic supplemental material |
|---|
|
|
|---|
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Bence, K., Ma, W., Kozasa, T., and Huang, X.Y. 1997. Direct stimulation of Bruton's tyrosine kinase by Gq-protein
-subunit. Nature 389: 296299.[CrossRef][Medline]
Ben-Naim, A. 1992. Statistical thermodynamics for chemists and biochemists. Plenum Press, New York, NY.
Bolen, J.B. 1995. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr. Opin. Immunol. 7: 306311.[CrossRef][Medline]
Bolland, S., Pearse, R.N., Kurosaki, T., and Ravetch, J.V. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8: 509516.[CrossRef][Medline]
Brazin, K.N., Fulton, D.B., and Andreotti, A.H. 2000. A specific intermolecular association between the regulatory domains of a Tec family kinase. J. Mol. Biol. 302: 607623.[CrossRef][Medline]
Chen, J. and Schreiber, S.L. 1994. SH3 Domain-mediated dimerization of an N-terminal fragment of the phosphatidylinositol 3-kinase p85 subunit Bioorganic and Med. Chem. Lett. 4: 17551760.[CrossRef]
Cheng, G., Ye, Z.-S., and Baltimore, D. 1994. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. 91: 81528155.
Cheng, J.S. and Shirts, R.B. 1985. Iterative determination of the monomer shift and dimerization constant in a self-associating system J. Phys. Chem. 89: 16431646.[CrossRef]
Davidson, N. 1962. Statistical mechanics. McGraw-Hill, New York, NY.
Duriez, B. Duquesnoy, P. Dastot, F., Bougneres, P. Amselem, S., and Goossens, M. 1994. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency FEBS Lett. 346: 165170.[CrossRef][Medline]
Feng, S., Chen, J.K., Yu, H., Simon, J.A., and Schreiber, S.L. 1994. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266: 12411257.
Feng, S., Kasahara, C., Rickles, R.J., and Schreiber, S.L. 1995. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. 92: 1240812415.
Hansson, H., Mattsson, P.T., Allard, P., Haapaniemi, P., Vihinen, M., Smith, C.I.E., and Hard, T. 1998. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37: 29122924.[CrossRef][Medline]
Hansson, H., Okoh, M.P., Smith, C.I.E., Vihinen, M., and Hard, T. 2001. Intermolecular interactions between the SH3 domain and the proline-rich TH region of Bruton's tyrosine kinase. FEBS Lett. 489: 6770.[CrossRef][Medline]
Heyeck, S.D. and Berg, L.J. 1993. Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc. Natl. Acad. Sci. 90: 669673.
Hyvonen, M. and Saraste, M. 1997. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: Molecular explanations for X-linked agammaglobulinaemia. EMBO J. 16: 33963404.[CrossRef][Medline]
Kawakami, Y., Yao, L., Miura, T., Tsukada, S., Witte, O.N., and Kawakami T. 1994. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol. Cell. Biol. 14: 51085113.
Koradi, R., Billeter, M., and Wüthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. Mol. Graph. 14: 2932.
Kuriyan, J. and Cowburn, D. 1997. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26: 259288.[CrossRef][Medline]
Lemmon, M.A., Ferguson, K.M., and Schlessinger, J. 1996. PH domains: Diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell 85: 621624.[CrossRef][Medline]
Li, Z., Wahl, M.I., Eguinoa, A., Stephens, L.R., Hawkins, P.T., and Witte, O.N. 1997. Phosphatidylinositol 3-kinase-
activates Bruton's tyrosine kinase in concert with Src family kinases. Proc. Natl. Acad. Sci. 94: 1382013825.
Ma, Y.C. and Huang, X.Y. 1998. Identification of the binding site for Gq
on its effector Bruton's tyrosine kinase. Proc. Natl. Acad. Sci. 95: 1219712201.
Mano, H. 1999. Tec family of protein-tyrosine kinases: An overview of their structure and function.Cytokine Growth Factor Rev. 10: 267280.[CrossRef][Medline]
Markley, J.L., Bax A., Arata, Y., Hilbers, C.W., Kaptein, R., Sykes, B.D., Wright, P.E., and Wütrich, K. 1998. Recommendations for the presentation of NMR structures of proteins and nucleic acids. J. Magn. Reson. 12: 123.
Mori, S., Abeygunawardana, C., O'Neil Johnson, M., and van Zijl, P.C.M. 1995. Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Magn. Reson. B108: 9498.[CrossRef][Medline]
Nisitani, S., Kato, R.M., Rawlings, D.J., Witte, O.N., and Wahl, M.I. 1999. In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies. Proc. Natl. Acad. Sci. 96: 22212226.
Ohta, Y., Haire, R.N., Litman, R.T., Fu, S.M., Nelson, R.P., Kratz, J., Kornfeld, S.J., Morena, M., Good, R.A., and Litman, G.W. 1994. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X chromosomelinked agammaglobulinemia. Proc. Natl. Acad. Sci. 91: 90629066.
Rawlings, D.J. and Witte, O.N. 1995. The Btk subfamily of cytoplasmic tyrosine kinases: Structure, regulation and function. Semin. Immunol. 7: 237246.[CrossRef][Medline]
Sicheri, F., Moarefi, I., and Kuriyan, J. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602609.[CrossRef][Medline]
Siliciano, J.D., Morrow, T.A., and Desiderio, S.V. 1992. Developmental regulation of a murine T-cellspecific tyrosine kinase gene, Tsk. Proc. Natl. Acad. Sci. 89: 1119411198.
Tsukada, S., Saffran, D.C., Rawlings, D.J., Parolini, O., Allen, R.C., Klisak, I., Sparks, R.S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J.W., Cooper, M.D., Conley, M.E., and Witte, O.N. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279290.[CrossRef][Medline]
Tzeng, S.R., Lou, Y.C., Pai, M.T., Jain, M.L., and Cheng, J.W. 2000. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl. J. Biomol. NMR 16: 303312.[CrossRef][Medline]
Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R., Bobrow, M., Smith, C.I.E., and Bentley, D.R. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361: 226232.[CrossRef][Medline]
Vihinen, M., Kwan, S.P., Lester, T., Ochs, H.D., Resnick, I., Valiaho, J., Conley, M.E., and Smith, C.I. 1999. Mutations of the human BTK gene coding for Bruton's tyrosine kinase in X-linked agammaglobulinemia. Hum. Mutat. 13: 280285.[CrossRef][Medline]
Vihinen, M., Nilsson, L., and Smith, C.I.E. 1994. Tec homology (TH) adjacent to the PH domain. FEBS Lett. 350: 263265.[CrossRef][Medline]
Xu, W., Harrison, S.C., and Eck, M.J. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595602.[CrossRef][Medline]
Yang, W. Malek, S.N., and Desiderio, S. 1995. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J. Biol. Chem. 270: 2083220840.
Yu, H., Rosen, M.K., Shin, T.B., Seidel-Dugan, C., Brugge, J.S. and Schreiber, S.L. 1992. Solution structure of the SH3 domain of Src and identification of its ligand binding site. Science 258: 16651668.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-X. Zhou Quantitative Relation between Intermolecular and Intramolecular Binding of Pro-Rich Peptides to SH3 Domains Biophys. J., November 1, 2006; 91(9): 3170 - 3181. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Feldhahn, F. Klein, J. L. Mooster, P. Hadweh, M. Sprangers, M. Wartenberg, M. M. Bekhite, W.-K. Hofmann, S. Herzog, H. Jumaa, et al. Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells J. Exp. Med., June 6, 2005; 201(11): 1837 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Tomlinson, V. L. Heath, C. W. Turck, S. P. Watson, and A. Weiss SHIP Family Inositol Phosphatases Interact with and Negatively Regulate the Tec Tyrosine Kinase J. Biol. Chem., December 31, 2004; 279(53): 55089 - 55096. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schmidt, E. van den Akker, M. Parren-van Amelsvoort, G. Litos, M. de Bruijn, L. Gutierrez, R. W. Hendriks, W. Ellmeier, B. Lowenberg, H. Beug, et al. Btk Is Required for an Efficient Response to Erythropoietin and for SCF-controlled Protection against TRAIL in Erythroid Progenitors J. Exp. Med., March 15, 2004; 199(6): 785 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Wilcox and L. J. Berg Itk Phosphorylation Sites Are Required for Functional Activity in Primary T Cells J. Biol. Chem., September 26, 2003; 278(39): 37112 - 37121. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Tibaldi and E. L. Reinherz CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities Int. Immunol., March 1, 2003; 15(3): 313 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Takesono, L. D. Finkelstein, and P. L. Schwartzberg Beyond calcium: new signaling pathways for Tec family kinases J. Cell Sci., January 8, 2002; 115(15): 3039 - 3048. |